Pamela E. Scott

1.2k total citations · 1 hit paper
19 papers, 843 citations indexed

About

Pamela E. Scott is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Pamela E. Scott has authored 19 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 5 papers in Obstetrics and Gynecology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Pamela E. Scott's work include Pregnancy and Medication Impact (10 papers), Maternal Mental Health During Pregnancy and Postpartum (6 papers) and Pregnancy and preeclampsia studies (5 papers). Pamela E. Scott is often cited by papers focused on Pregnancy and Medication Impact (10 papers), Maternal Mental Health During Pregnancy and Postpartum (6 papers) and Pregnancy and preeclampsia studies (5 papers). Pamela E. Scott collaborates with scholars based in United States, Thailand and Switzerland. Pamela E. Scott's co-authors include Susan E. Andrade, Sengwee Toh, Tarek A. Hammad, Pamala A. Pawloski, Robert L. Davis, Sascha Dublin, William O. Cooper, Marsha A. Raebel, Merina Elahi and Marjorie Jenkins and has published in prestigious journals such as Journal of the American College of Cardiology, Obstetrics and Gynecology and Frontiers in Pharmacology.

In The Last Decade

Pamela E. Scott

19 papers receiving 826 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

2018 233 citations Pamela E. Scott, Ellis F. Unger et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela E. Scott United States	12	513	260	190	144	85	19	843
Mary K. Kowal United States	11	338 0.7×	177 0.7×	151 0.8×	59 0.4×	99 1.2×	11	686
Nonna Heiskanen Finland	15	269 0.5×	555 2.1×	530 2.8×	153 1.1×	15 0.2×	25	1.1k
Emily Johnston United States	6	153 0.3×	354 1.4×	352 1.9×	114 0.8×	39 0.5×	14	642
Leyla Şahin United States	14	533 1.0×	300 1.2×	223 1.2×	21 0.1×	24 0.3×	34	791
Sandra M. Dumanski Canada	12	152 0.3×	78 0.3×	70 0.4×	92 0.6×	50 0.6×	37	488
Maryam Sattari United States	16	182 0.4×	90 0.3×	125 0.7×	76 0.5×	9 0.1×	34	848
David Acker United States	15	212 0.4×	542 2.1×	391 2.1×	92 0.6×	20 0.2×	37	955
Sarah Vause United Kingdom	14	166 0.3×	257 1.0×	240 1.3×	126 0.9×	17 0.2×	45	641
Elizabeth Camacho United Kingdom	16	142 0.3×	78 0.3×	54 0.3×	61 0.4×	79 0.9×	54	774
Anna Palatnik United States	16	236 0.5×	367 1.4×	420 2.2×	43 0.3×	18 0.2×	105	849

Countries citing papers authored by Pamela E. Scott

Since Specialization

Citations

This map shows the geographic impact of Pamela E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela E. Scott more than expected).

Fields of papers citing papers by Pamela E. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela E. Scott. The network helps show where Pamela E. Scott may publish in the future.

Co-authorship network of co-authors of Pamela E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela E. Scott. A scholar is included among the top collaborators of Pamela E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela E. Scott. Pamela E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Berry‐Bibee, Erin, Diana Blithe, Ruth S. Day, et al.. (2018). FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”. The Journal of Clinical Pharmacology. 58(12). 1655–1665. 15 indexed citations

Scott, Pamela E., Ellis F. Unger, Marjorie Jenkins, et al.. (2018). Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs. Journal of the American College of Cardiology. 71(18). 1960–1969. 233 indexed citations breakdown →

Feuerstein, Irwin M., Marjorie Jenkins, Susan G. Kornstein, et al.. (2018). Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium. Journal of Women s Health. 27(10). 1195–1203. 8 indexed citations

Miller, Leah, Emmanuel O. Fadiran, Rajeev Agarwal, et al.. (2016). The science of sex and gender in human health: online courses to create a foundation for sex and gender accountability in biomedical research and treatment. Biology of Sex Differences. 7(S1). 47–47. 8 indexed citations

Peer, Cody J., Jonathan D. Strope, Shaunna Beedie, et al.. (2016). Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats. Frontiers in Pharmacology. 7. 260–260. 7 indexed citations

Elahi, Merina, Helen M. Barr, Beverly Lyn‐Cook, et al.. (2016). The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update. Journal of Women s Health. 25(3). 222–234. 10 indexed citations

Alfa, Michelle J., et al.. (2016). A Roundtable Discussion: Combating the Complex Challenge of Healthcare-Associated Infections. Biomedical Instrumentation & Technology. 50(4). 282–288. 2 indexed citations

Avalos, Lyndsay A., Hong Chen, Chunmei Yang, et al.. (2013). The Prevalence and Trends of Antiviral Medication Use During Pregnancy in the US: A Population-Based Study of 664,297 Deliveries in 2001–2007. Maternal and Child Health Journal. 18(1). 64–72. 5 indexed citations

Lawrence, Jean M., Susan E. Andrade, Lyndsay A. Avalos, et al.. (2013). Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007. Obstetrics and Gynecology. 121(1). 106–114. 27 indexed citations

10.

Toh, Sengwee, Qian Li, T. Craig Cheetham, et al.. (2013). Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001–2007: a population-based study of 585,615 deliveries. Archives of Women s Mental Health. 16(2). 149–157. 100 indexed citations

11.

Johnson, Karin, Sarah J. Beaton, Susan E. Andrade, et al.. (2013). Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiology and Drug Safety. 22(7). 776–782. 21 indexed citations

12.

Li, Qian, Susan E. Andrade, William O. Cooper, et al.. (2013). Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiology and Drug Safety. 22(5). 524–532. 88 indexed citations

13.

Bobo, William V., Robert L. Davis, Sengwee Toh, et al.. (2012). Trends in the Use of Antiepileptic Drugs among Pregnant Women in the US, 2001–2007: A Medication Exposure in Pregnancy Risk Evaluation Program Study. Paediatric and Perinatal Epidemiology. 26(6). 578–588. 63 indexed citations

14.

Hansen, Craig, Peter Joski, Susan Andrade, et al.. (2012). Medication Exposure in Pregnancy Risk Evaluation Program: The Prevalence of Asthma Medication Use During Pregnancy. Maternal and Child Health Journal. 17(9). 1611–1621. 33 indexed citations

15.

Andrade, Susan E., Pamela E. Scott, Robert L. Davis, et al.. (2012). Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiology and Drug Safety. 22(1). 7–15. 107 indexed citations

16.

Andrade, Susan E., Robert L. Davis, T. Craig Cheetham, et al.. (2011). Medication Exposure in Pregnancy Risk Evaluation Program. Maternal and Child Health Journal. 16(7). 1349–1354. 51 indexed citations

17.

Andrade, Susan E., Marsha A. Raebel, Jeffrey S. Brown, et al.. (2008). Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiology and Drug Safety. 17(3). 240–247. 46 indexed citations

18.

Obias-Manno, Dulce, Pamela E. Scott, J Kaczmarczyk, et al.. (2007). The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy. Journal of Women s Health. 16(6). 807–817. 13 indexed citations

19.

Scott, Pamela E. & Gregory Campbell. (1998). Interpretation of Subgroup Analyses in Medical Device Clinical Trials. Drug Information Journal. 32(1). 213–220. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact